16750311000001109: Ofatumumab (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

58722401000001119 Ofatumumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

58722501000001115 Ofatumumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ofatumumab	Is a	Monoclonal antibody agent	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ofatumumab 100mg/5ml solution for infusion vials	Has specific active ingredient	False	Ofatumumab	Inferred relationship	Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd)	Has specific active ingredient	False	Ofatumumab	Inferred relationship	Existential restriction modifier
Ofatumumab 100mg/5ml solution for infusion vials 10 vial	Has specific active ingredient	False	Ofatumumab	Inferred relationship	Existential restriction modifier
Ofatumumab 100mg/5ml solution for infusion vials 3 vial	Has specific active ingredient	False	Ofatumumab	Inferred relationship	Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 3 vial	Has specific active ingredient	False	Ofatumumab	Inferred relationship	Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 10 vial	Has specific active ingredient	False	Ofatumumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets